Large-scale testing (Phase 3)Ended earlyNCT01900665
What this trial is testing
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 2,129
Showing 20 of 0 results